Authors: Jendle JH, Garg SK, Thivolet C, Weinstock RS, Hirsch IB, Evans M, Griffin KJ, Philis-Tsimikas A, Wheeler BJ, Kipnes MS, Carlson AL, Buckingham BA, Bhargava A, Bode BW, Lawson ML, Criego AB, McGill JB, Reed JCH, Prakasam G, Grunberger G, Girelli A, Martinez-Brocca MA, Christiansen MP, de Bock MI, Kudva YC, Lee SW, Yovanovich C, Shin JJ, Cordero TL, McVean JJF, Vigersky RA.
DOI: 10.3389/fendo.2025.1716587
Abstract Summary
Automated insulin delivery systems significantly outperformed traditional multiple daily injections in a large international trial of 252 people with type 1 diabetes. After 6 months, the MiniMed 670G/770G systems reduced HbA1c levels by 0.7% and decreased time spent in hypoglycemia, while maintaining safety across all age groups from children to adults.
Why Brain? đź§
Automated insulin delivery systems significantly improved blood sugar control and reduced dangerous low blood sugar episodes compared to standard insulin injections in type 1 diabetes patients.
License: CC BY.
The image is AI-generated for illustrative purposes only. Courtesy of Midjourney.
